Cargando…
Animal experiments show impact of vaccination on reduction of SARS-CoV-2 virus circulation: A model for vaccine development?
BACKGROUND: In the pre-clinical phase, SARS-CoV-2 vaccines were tested in animal models, including exposure trials, to investigate protection against SARS-CoV-2. These studies paved the way for clinical development. The objective of our review was to provide an overview of published animal exposure...
Autores principales: | Vandeputte, J., Van Damme, P., Neyts, J., Audonnet, J.C., Baay, M., Neels, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414133/ https://www.ncbi.nlm.nih.gov/pubmed/34489162 http://dx.doi.org/10.1016/j.biologicals.2021.08.001 |
Ejemplares similares
-
SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
por: Baay, Marc, et al.
Publicado: (2020) -
Controlled Human Infection to Speed Up SARS-CoV-2 Vaccine Development
por: Baay, Marc, et al.
Publicado: (2021) -
Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic
por: Baay, Marc, et al.
Publicado: (2021) -
SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues
por: Baay, Marc, et al.
Publicado: (2020) -
IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?
por: Vandeputte, Joris, et al.
Publicado: (2021)